Diabetes Cure News
|

Diabetes Cure News Type 1

Bydiabetesknow

Diabetes Cure News!

Johnson & Johnson is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix and essentially cure the life-threatening hormonal disorder type 1 diabetes.

ViaCyte has already begun testing the device in a small number of diabetic patients. If it works as well in patients as it has in animals, it would amount to a cure, ending the need for frequent insulin injections and blood sugar testing. Watch the FOX5 news report above!

Read more about stem cells technology by ViaCyte.

I'm a type 1 diabetic with diabetes knowledge in t1d and t2d, as well as nutrition and low-carb keto diet information, fitness and exercise programs to help keep you in optimal diabetes health. Take advantage of our diabetic health tools for a healthier lifestyle!

Similar Posts

DRI BioHub Biological Cure for Diabetes

DRI’s BioHub Possible Biological Cure for Diabetes

Bydiabetesknow

Diabetes Research Institute or (DRI) for short, have what their scientists are calling a possible biological cure for diabetes called the BioHub. The BioHub is a crafted “mini body organ” that houses insulin-producing islet cells that sense blood sugar as well as introduce the specific volume of the hormone insulin to keep blood sugar levels…

Implant Reverses Type 1 Diabetes in Mice by Delivering Beta Cells
|

Implant Reverses Type 1 Diabetes in Mice by Delivering Beta Cells

Bydiabetesknow

Previously Published on Medical News Today – New research uses stem cells and a tiny device, the implant reverses type 1 diabetes in mice. Insulin-secreting beta cells can reverse type 1 diabetes in mice. Introducing these cells without triggering the immune system has been a critical challenge. Researchers have developed an apparently safe, functional device for delivery…

Diabetes Cured in Mice Using New Human Stem Cell Therapy

Diabetes Cured in Mice Using New Human Stem Cell Therapy

Bydiabetesknow

Diabetes Cured in Mice Using New Human Stem Cell Therapy Researchers from Washington University School of Medicine have cured mice of diabetes using a new human stem cell therapy. The technique converts human stem cells into insulin-producing cells. When the insulin secreting cells were infused into mice with severe diabetes, within two weeks their blood glucose…

Bionic Pancreas Critical Hurdle
|

Bionic Pancreas Critical Hurdle, iLet

Bydiabetesknow

Bionic Pancreas Critical Hurdle! Beta Bionics recently won $12 million in supplemental funding from the National Institutes of Health (NIH) to conduct a major multicenter, national clinical trials for the iLet™ (bionic pancreas). Developed by Edward Damiano (Beta Bionics) and Firas El-Khatib. They hope to have the device approved for market in about a year….

Neo-Islets
|

Neo Islets Possible T1D Cure

Bydiabetesknow

Scientists at SymbioCellTech (SCT) have developed a technology called Neo Islets for possible type 1 diabetes (T1D) cure. It combines Mesenchymal Stem Cells (MSCs) with culture-expanded pancreatic islet cells to form three-dimensional cellular clusters. The scientists performed the technique in mice. All treated mice demonstrated normal blood glucose control without the need for anti-rejection drugs or encapsulation devices….

Breakthroughs in Pancreatic Cell Replacement ViaCyte Interview

Breakthroughs in Pancreatic Cell Replacement: ViaCyte Interview

Bydiabetesknow

Previously Published on Diabetes Daily ViaCyte Interview By Christine Fallabel – I recently had the opportunity to sit down with Manasi Sinha Jaiman, M.D., M.P.H., Vice President of Clinical Development, and Mark Daniels, Senior Director of Clinical Development, of ViaCyte, “a regenerative medicine company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for all…